Address	Canadian Venture Building Toronto Ontario M5C 1P1 Canada
Employees	-
Website	http://cotingapharma.com
Updated	07/08/2019
Cotinga Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of cancer and other unmet medical needs. Its lead product candidate, COTI-2, treats ovarian and other gynecological cancers and restores normal cell signaling in cancer with p53 mutations. The company was founded on October 13, 2006 and is headquartered in London, Canada.